Seyn Biologics Private Limited
Founded in 2023 and headquartered in Telangana, India.
2023 | Hyderabad, Telangana (India) | Active
Seyn Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
About Seyn Biologics
Seyn Biologics Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 September 2023 (One year and five months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Venkataramana Mudili and Anura Silva serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21001TS2023PTC177390
- Company No.
177390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Seyn Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkataramana Mudili  | Director | 22-Sep-2023 | Current |
Anura Silva  | Additional Director | 21-Mar-2024 | Current |
Financial Performance of Seyn Biologics.
Enhance accessibility to Seyn Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Seyn Biologics?
Unlock access to Seyn Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lorven Biologics Private LimitedVenkataramana Mudili is a mutual person
- Biotris Biologics Private Limited
Venkataramana Mudili is a mutual person
- Lorven Vetcare Private Limited
Venkataramana Mudili is a mutual person
- Srk Cleanrooms Private Limited
Venkataramana Mudili is a mutual person
- S & D Textill India Private Limited
Anura Silva is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Seyn Biologics?
Unlock and access historical data on people associated with Seyn Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seyn Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seyn Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
